Trading Tips Blog

Timothy Springer, a director and major owner at
Selecta Biosciences (SELB), recently bought 3,185,394 shares of the company. That trade came to over $5.4 million. The buy increased his total holdings to just over 16.05 million shares. Another director made a 50,000 share buy at the start of October as well. There have been some insider sales in the past year, but they have been dwarfed by insider buys. Insiders own 17 percent of all shares of the immunogenetics company. Shares of ...
Read More About This

Over 1,950 contracts traded on the November 27th $25 calls on
Carnival Cruise (CCL). The prior open interest on the trade was 137 contracts, showing a 14-fold rise in volume. The trade, expiring in 44 days, has a strike price 75 percent higher than where shares currently trade around $14.25. With that big of a price difference, it’s no surprise that the buyer of the contract only paid about $0.13, or just $13 per contract, on average. As it’s unlikely for shares of ...
Read More About This

Citigroup recently upgraded one major consumer goods play following a strong earnings beat. Thanks to stay-at-home trends, this company has fared relatively well, even better than peers. That’s led to the view that this company will continue to show strong growth into 2021. Even better, this company lags competitors in terms of operating margins. As a result, shares look likely to offer multiple expansion as well, which could lead to even bigger returns. The company?
PepsiCo (PEP). Best known as the second-largest player ...
Read More About This

Richard Anderson, a director at
Medtronic PLC (MDT), recently added 4,607 shares. The buy came to a total purchase price of nearly $51,000, and increased the director’s stake by 4.4 percent. This is the second insider buy of 2020, following a buy from the company CEO back in February. Insiders have been a mix of buyers and sellers this year. The share price of the company has held up relatively well in the past year. Although sales and earnings are slightly off in ...
Read More About This

Nearly 9,100 contracts traded on the June 2021 $640 calls on
Tesla Motors (TSLA) recently. That’s a 12-fold rise over the prior open interest of 766 contracts. The trade, expiring in 248 days, would require shares to rally about 45 percent from their current price. The option buyer paid about $51.90, or $5,190 per contract to make the far out-of-the-money trade. Shares of the company have been one of the top performers in the past year. While a 45 percent move in shares ...
Read More About This

James Filler, a major owner at
Century Bancorp (CNBKA), recently added 1,002 shares to his stake. A mere 0.12 percent increase, the $69,000 buy increased his holdings to over 848,000 shares. This follows on top of some small share buys from company executives earlier in the month, although Filler has been the major buyer of shares in the past year. The Massachusetts based-bank has 27 offices in the state. Shares have shed 21 percent in the past year, as the decline in ...
Read More About This

Nearly 2,100 contracts traded on the November 20th $110 puts on
Xilinx (XLNX) recently. The trades amounted to an 18-fold rise in volume on the trade based on the prior open interest of 114 contracts. Expiring in 39 days, the trade is a bet that shares will shed about $9 from their current price near $119. Shares of the tech company soared on Friday on the announcement that Advanced Micro Devices was in advanced talks to buy the firm. The buyer of the ...
Read More About This

Industrial companies have been out of favor plays in this market. Some companies have fared even worse, having struggled even while the economy was looking rosy. One of the most unloved names in the space just got a major upgrade with a potential 50 percent move higher in the next year. In fact, an analyst at Goldman Sachs just called this company the “ultimate self-help, vaccine-leverage story,” in the sector. That company?
General Electric (GE). GE has spent the last two years ...
Read More About This